The National Cancer Institute is now offering a "Risk Disk"

The National Cancer Institute is now offering a "Risk Disk"...a computer program to help women estimate their risk of developing breast cancer.

This is important now that Nolvadex (tamoxifen) is approved to reduce the incidence of breast cancer in women at high risk.

The Risk Disk asks about the woman's age...age of menarche...age at first live birth...family history of breast cancer...and personal medical history.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote